Correlation Engine 2.0
Clear Search sequence regions

  • bone (12)
  • bone substitutes (2)
  • OPN (1)
  • osteocalcin (1)
  • osteogenesis (1)
  • rabbits (1)
  • ulna (4)
  • Sizes of these terms reflect their relevance to your search.

    The aim of this study was to develop novel hydroxyapatite (HAP)-based bioactive bone replacement materials for segmental osteotomy reconstruction. Customized three-dimensional (3D) bone construct was manufactured from nanohydroxyapatite (nHAP) with poly(lactide-co-glycolide) (PLGA) coating using 3D models derived from the computed tomography (CT) scanning of the rabbit's ulna and gradient 3D printing of the bone substitute mimicking the anatomical shape of the natural bone defect. Engineered construct revealed adequate micro-architectural design for successful bone regeneration having a total porosity of 64% and an average pore size of 256 μm. Radiography and micro-CT analysis depicted new bone apposition through the whole length of the reconstructed ulna with a small area of non-resorbed construct in the central area of defect. Histological analysis revealed new bone formation with both endochondral and endesmal type of ossification. Immunohistochemistry analysis depicted the presence of bone formation indicators - bone morphogenetic protein (BMP), osteocalcin (OCN) and osteopontin (OPN) within newly formed bone. Manufactured personalized construct acts as a "smart" responsive biomaterial capable of modulating the functionality and potential for the personalized bone reconstruction on a clinically relevant length scale.


    Milutin Micic, Djordje Antonijevic, Sanja Milutinovic-Smiljanic, Dijana Trisic, Bozana Colovic, Dejana Kosanovic, Bogomir Prokic, Jugoslav Vasic, Slavoljub Zivkovic, Jelena Milasin, Vesna Danilovic, Marija Djuric, Vukoman Jokanovic. Developing a novel resorptive hydroxyapatite-based bone substitute for over-critical size defect reconstruction: physicochemical and biological characterization and proof of concept in segmental rabbit's ulna reconstruction. Biomedizinische Technik. Biomedical engineering. 2020 Aug 27;65(4):491-505

    Expand section icon Mesh Tags

    Expand section icon Substances

    PMID: 32335536

    View Full Text